Cargando…
Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future
Traditionally, neoadjuvant treatment for breast cancer was preserved for locally advanced and inflammatory disease, converting an inoperable to a surgical resectable cancer. In recent years, neoadjuvant therapy has become an accepted treatment option also for lower tumor stages in order to increase...
Autores principales: | Gampenrieder, Simon P., Rinnerthaler, Gabriel, Greil, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762209/ https://www.ncbi.nlm.nih.gov/pubmed/24027583 http://dx.doi.org/10.1155/2013/732047 |
Ejemplares similares
-
SABCS 2016: systemic therapy for metastatic breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017) -
ASCO 2018 highlights: metastatic breast cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2018) -
CDK4/6 inhibition in luminal breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2016) -
HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2019) -
Cure in metastatic breast cancer
por: Westphal, Theresa, et al.
Publicado: (2018)